LCA-Vision's EPS (Basic) for the
three
months ended in Mar. 2014 was €-0.01.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2014 was €-0.11.
LCA-Vision's EPS without NRI for the
three
months ended in Mar. 2014 was €-0.01.
Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2014 was €-0.11.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
LCA-Vision EPS (Diluted) Historical Data
The historical data trend for LCA-Vision's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LCA-Vision's EPS (Diluted)
For the Medical Care Facilities subindustry, LCA-Vision's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LCA-Vision's PE Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LCA-Vision's PE Ratio distribution charts can be found below:
* The bar in red indicates where LCA-Vision's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
LCA-Vision's Diluted EPS for the fiscal year that ended in Dec. 2013 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.11
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LCA-Vision (FRA:LCV1) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
LCA-Vision EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of LCA-Vision's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
LCA-Vision, Inc., is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. Its vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. Its vision centers are supported by ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in its vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. It provides two types of procedures in its vision centers namely LASIK; and PRK and Surface Ablation. It began performing LASIK, in 1996, which continues to account for the majority of the laser vision correction procedures performed in the United States. In LASIK procedures, its surgeon's uses a femtosecond laser to create a thin flap, which remains hinged to the eye. In PRK procedures, the ophthalmologist removes the thin layer of cells covering the outer surface of the cornea (the epithelium) in order to apply the excimer laser pulses directly to the surface of the cornea. Following the PRK procedure, the ophthalmologist places a bandage contact lens on the eye to protect it. Most of its patients currently receive a procedure called laser-assisted in situ keratomileusis ('LASIK'), which it began performing in the United States in 1996. As of December 31, 2012, it operated 54 LasikPlus fixed-site laser vision correction centers generally located in metropolitan markets in the United States, including two vision centers licensed to ophthalmologists who operate using its trademarks. It currently uses two suppliers for its fixed-site excimer lasers: Abbott Medical Optics ('AMO') and Alcon Inc. ('Alcon'). Its business is heavily dependent on advertising, which is subject to regulation by the Federal Trade Commission ('FTC').
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:LCV1 has been successfully added to your 